News | July 08, 2014

Huntington Memorial Hospital Implants Non-surgical, Leadless Cardiac Pacemaker

July 8, 2014 — A Huntington Memorial Hospital patient has become the first patient in the San Gabriel Valley in southern California to be implanted with a tiny, leadless cardiac pacemaker. Developed for patients with bradycardia, St. Jude Medical’s Nanostim device is designed to be placed directly in a patient’s heart without the visible lump, scar and insulated wires (leads) required for conventional pacemakers.

The implant took place as part of the LEADLESS II pivotal trial, a prospective, non-randomized, multicenter, international clinical study designed to evaluate the safety and effectiveness of the Nanostim leadless pacemaker in patients indicated for the device in the United States. The study is expected to enroll approximately 670 patients at 50 centers. The procedure was successfully performed by cardiologists David Mok, M.D., and Mayer Rashtian, M.D., FACC, FHRS, director of electrophysiology.

“The procedure is less invasive than traditional pacemaker surgery, which reduces the risk of infection or other complications,” said Mok. “Huntington is committed to continuous quality improvement and being on the forefront of new treatments and technologies. We are exceptionally pleased to be part of this worldwide trial and among the first to perform the implant."

Implanted via the femoral vein with a steerable catheter, the Nanostim pacemaker offers physicians a less-invasive approach compared to traditional pacemaker procedures that require more extensive surgery. The miniaturized device is designed to be fully retrievable so that it can be readily repositioned during the implant procedure and later retrieved if necessary.

It is less than 10 percent the size of a conventional pacemaker and is the least invasive pacing technology available today. The small size of the device and lack of a surgical pocket, coupled with the exclusion of a lead, improves patient comfort and can reduce complications, including device pocket-related infection and lead failure. The elimination of the visible lump and scar at a conventional pacemaker’s implant site, in addition to the removal of patient activity restrictions that are routinely put in place in an attempt to prevent dislodgement or damage to a conventional lead, will potentially improve the quality of life for patients with this technology by allowing most to continue living active, uninhibited lifestyles. The device is supported by the St. Jude Medical Merlin programmer, which is also used to interrogate and program the company’s other pacemakers and implantable cardioverter defibrillators (ICDs).

The Nanostim leadless pacemaker received CE mark approval in 2013 and is now available in select European markets. The device is not available for sale in the United States

For more information: www.sjm.com/leadlesspacing, www.huntingtonhospital.com

Related Content

Biotronik Launchs His-Bundle Pacing Tools
News | Pacemakers | June 16, 2020
June 16, 2020 - Biotronik has today announced its commitment to giving physicians additional tools to pace in the His
Videos | Pacemakers | February 13, 2020
This video illustrates how the Micra AV leadless pacemaker is delivered via catheter and enables atrioventricular (AV
The Micra AV leadless pacemaker
News | Pacemakers | February 13, 2020
February 13, 2020 — The U.S.
Results from the MARVEL 2 (Micra Atrial Tracking Using A Ventricular accELerometer) study shows that an investigational set of algorithms in the Medtronic Micra Transcatheter Pacing System (TPS) significantly improves synchrony and cardiac function in patients with atrioventricular (AV) block. This is an impaired electrical conduction between the chambers of the heart.
News | Pacemakers | November 15, 2019
(February 2020 update — the results of this trial led to the FDA clearnace of the Micra AV device in January 2020
Co-principal investigator professor Aydin Babakhani at the UCLA Integrated Sensor Laboratory holds an earlier version of the prototype leadless, wireless amnd batteryless pacemaker. Photo Credit: Cody Duty, Texas Medical Center.

Co-principal investigator professor Aydin Babakhani at the UCLA Integrated Sensor Laboratory holds an earlier version of the prototype leadless, wireless and battery-less pacemaker. Photo Credit: Cody Duty, Texas Medical Center.

News | Pacemakers | November 13, 2019
FDA Warns of Premature Battery Depletion in Some Medtronic Pacemakers
News | Pacemakers | May 07, 2019 | Dave Fornell, Editor
The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare providers and patients...
Artificial Intelligence Can Improve Emergency X-ray Identification of Pacemakers
News | Pacemakers | March 29, 2019
A research team from Imperial College London believes a new software could speed up the diagnosis and treatment of...
Medtronic Recalls Dual Chamber Pacemakers
News | Pacemakers | February 20, 2019
Medtronic is recalling its dual chamber implantable pulse generators (IPGs) due to the possibility of a software error...
CHLA/USC Team Designs Novel Micropacemaker

Model of the human heart with microprocessor located in the pericardial sac and attached to the left ventricle. Graphic courtesy of Business Wire.

News | Pacemakers | June 29, 2018
Investigators at Children's Hospital Los Angeles (CHLA) and the University of Southern California (USC) have...
Permanent Pacing Effective for Older Patients With Syncope and Bifascicular Block
News | Pacemakers | May 24, 2018
Syncope with bifascicular block may be caused by intermittent complete heart block, but competing diagnoses may coexist...